Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 29;11(10):2557.
doi: 10.3390/nano11102557.

Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System

Affiliations
Review

Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System

Kalvatala Sudhakar et al. Nanomaterials (Basel). .

Abstract

A selected active pharmaceutical ingredient must be incorporated into a cargo carrier in a particular manner so that it achieves its goal. An amalgamation of active pharmaceutical ingredients (APIs) should be conducted in such a manner that it is simple, professional, and more beneficial. Lipids/polymers that are known to be used in nanocarriers for APIs can be transformed into a vesicular formulation, which offers elegant solutions to many problems. Phospholipids with other ingredients, such as ethanol and water, form suitable vesicular carriers for many drugs, overcoming many problems related to poor bioavailability, poor solubility, etc. Ultraflexible liposomes are novel carriers and new frontiers of drug delivery for transdermal systems. Auxiliary advances in vesicular carrier research have been made, enabling polymer-coated ethanolic liposomes to avoid detection by the body's immune system-specifically, the cells of the reticuloendothelial system. Ultraflexible liposomes act as a cargo system and a nanotherapeutic approach for the transport of therapeutic drugs and bioactive agents. Various applications of liposome derivatives in different diseases are emphasized in this review.

Keywords: bioactive; ethosome; liposome; transethosomes; transfersomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Different vesicular carriers with defined layers and composition.
Figure 2
Figure 2
Mechanism of the vesicular carrier crossing the stratum corneum of the skin.
Figure 3
Figure 3
Different vesicular carriers with different penetration capabilities (L: liposome; T: transfersome; E: ethosome; TE: transethosome).
Figure 4
Figure 4
Schematic and hypothetical diagram of PEG ethosome and ethosome release kinetics.

References

    1. Wilbur R.L. The Difference between Topical and Transdermal Medications. [(accessed on 13 March 2021)]. Available online: https://genscopharma.com/difference-topical-transdermal-medications/
    1. Sudhakar C.K., Upadhyay N., Jain S., Charyulu R.N. Ethosomes as Non-invasive Loom for Transdermal Drug Delivery. In: Sebastian M., Ninan N., Haghi A.K., editors. Nanomedicine and Drug Delivery. Volume 1. Apple Academic Press; San Diego, CA, USA: 2012. pp. 1–16.
    1. Ogunsola O.A., Kraeling M.E., Zhong S., Pochan D.J., Bronaugh R.L., Raghavan S.R. Structural analysis of “flexible” liposome formulations: New insights into the skin-penetrating ability of soft nanostructures. Soft Matter. 2012;8:10226–10232. doi: 10.1039/c2sm26614h. - DOI
    1. Singh S., Vardhan H., Kotla N.G., Maddiboyina B., Sharma D., Webster T.J. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic. Int. J. Nanomed. 2016;11:1475–1482. - PMC - PubMed
    1. Puglia C., Tirendi G.G., Bonina F. Emerging role of colloidal drug delivery systems (CDDS) in NSAID topical administration. Curr. Med. Chem. 2013;20:1847–1857. doi: 10.2174/0929867311320140004. - DOI - PubMed

LinkOut - more resources